Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy

被引:298
作者
Rubinshtein, Ronen [1 ]
Glockner, James F. [2 ]
Ommen, Steve R. [1 ]
Araoz, Philip A. [2 ]
Ackerman, Michael J. [1 ,3 ,4 ,5 ]
Sorajja, Paul [1 ]
Bos, J. Martijn [5 ]
Tajik, A. Jamil [6 ]
Valeti, Uma S. [1 ]
Nishimura, Rick A. [1 ]
Gersh, Bernard J. [1 ]
机构
[1] Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Pediat, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
[5] Mayo Clin, Windland Smith Rice Sudden Death Genom Lab, Rochester, MN 55905 USA
[6] Mayo Clin, Div Cardiovasc Dis, Scottsdale, AZ USA
关键词
hypertrophic cardiomyopathy; magnetic resonance imaging; late gadolinium enhancement; sudden death and risk assessment; SURGICAL SEPTAL MYECTOMY; SUDDEN CARDIAC DEATH; DELAYED ENHANCEMENT; RISK; YOUNG; DEFIBRILLATORS; SYMPTOMS; FIBROSIS; ABLATION;
D O I
10.1161/CIRCHEARTFAILURE.109.854026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Myocardial late gadolinium enhancement (LGE) on contrast-enhanced magnetic resonance imaging (CE-MRI) of patients with hypertrophic cardiomyopathy (HCM) has been suggested to represent intramyocardial fibrosis and, as such, an adverse prognostic risk factor. We evaluated the characteristics of LGE on CE-MRI and explored whether LGE among patients with HCM was associated with genetic testing, severe symptoms, ventricular arrhythmias, or sudden cardiac death (SCD). Methods and Results-Four hundred twenty-four patients with HCM (age=55+/-16 years [range 2 to 90], 41% females), without a history of septal ablation/myectomy, underwent CE-MRI (GE 1.5 Tesla). We evaluated the relation between LGE and HCM genes status, severity of symptoms, and the degree of ventricular ectopy on Holter ECG. Subsequent SCD and appropriate implanted cardioverter defibrillator (ICD) therapies were recorded during a mean follow-up of 43+/-14 months (range 16 to 94). Two hundred thirty-nine patients (56%) had LGE on CE-MRI, ranging from 0.4% to 65% of the left ventricle. Gene-positive patients were more likely to have LGE (P<0.001). The frequencies of New York Heart Association class >= 3 dyspnea and angina class >= 3 were similar in patients with and without LGE (125 of 239 [52%] versus 94 of 185 [51%] and 24 of 239 [10%] versus 18 of 185 [10%], respectively, P=NS). LGE-positive patients were more likely to have episodes of nonsustained ventricular tachycardia (34 of 126 [27%] versus 8 of 94 [8.5%], P<0.001), had more episodes of nonsustained ventricular tachycardia per patient (4.5+/-12 versus 1.1+/-0.3, P=0.04), and had higher frequency of ventricular extrasystoles/24 hours (700+/-2080 versus 103+/-460, P=0.003). During follow-up, SCD occurred in 4 patients, and additional 4 patients received appropriate ICD discharges. All 8 patients were LGE positive (event rate of 0.94%/y, P=0.01 versus LGE negative). Two additional heart failure-related deaths were recorded among LGE-positive patients. Univariate associates of SCD or appropriate ICD discharge were positive LGE (P=0.002) and presence of nonsustained ventricular tachycardia (P=0.04). The association of LGE with events remained significant after controlling for other risk factors. Conclusions-In patients with HCM, presence of LGE on CE-MRI was common and more prevalent among gene-positive patients. LGE was not associated with severe symptoms. However, LGE was strongly associated with surrogates of arrhythmia and remained a significant associate of subsequent SCD and/or ICD discharge after controlling for other variables. If replicated, LGE may be considered an important risk factor for sudden death in patients with HCM. (Circ Heart Fail. 2010; 3: 51-58.)
引用
收藏
页码:51 / 58
页数:8
相关论文
共 50 条
  • [31] Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis
    Kamp, Nicholas J.
    Chery, Godefroy
    Kosinski, Andrzej S.
    Desai, Milind Y.
    Wazni, Oussama
    Schmidler, Gillian Sanders
    Patel, Manesh
    Lopes, Renato D.
    Morin, Daniel P.
    Al-Khatib, Sana M.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2021, 66 : 10 - 16
  • [32] Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using machine learning
    Akita, Keitaro
    Suwa, Kenichiro
    Ohno, Kazuto
    Weiner, Shepard D.
    Tower-Rader, Albree
    Fifer, Michael A.
    Maekawa, Yuichiro
    Shimada, Yuichi J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2025, 421
  • [33] Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy
    Ismail, Tevfik F.
    Jabbour, Andrew
    Gulati, Ankur
    Mallorie, Amy
    Raza, Sadaf
    Cowling, Thomas E.
    Das, Bibek
    Khwaja, Jahanzaib
    Alpendurada, Francisco D.
    Wage, Ricardo
    Roughton, Michael
    McKenna, William J.
    Moon, James C.
    Varnava, Amanda
    Shakespeare, Carl
    Cowie, Martin R.
    Cook, Stuart A.
    Elliott, Perry
    O'Hanlon, Rory
    Pennell, Dudley J.
    Prasad, Sanjay K.
    HEART, 2014, 100 (23) : 1851 - 1858
  • [34] Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy
    Tezuka, Daisuke
    Kosuge, Hisanori
    Terashima, Masahiro
    Koyama, Nozomu
    Kishida, Tadashi
    Tada, Yuko
    Suzuki, Jun-ichi
    Sasano, Tetsuo
    Ashikaga, Takashi
    Hirao, Kenzo
    Isobe, Mitsuaki
    HEART AND VESSELS, 2018, 33 (05) : 513 - 520
  • [35] Comparison of different quantification methods of late gadolinium enhancement in patients with hypertrophic cardiomyopathy
    Spiewak, Mateusz
    Malek, Lukasz A.
    Misko, Jolanta
    Chojnowska, Lidia
    Milosz, Barbara
    Klopotowski, Mariusz
    Petryka, Joanna
    Dabrowski, Maciej
    Kepka, Cezary
    Ruzyllo, Witold
    EUROPEAN JOURNAL OF RADIOLOGY, 2010, 74 (03) : E150 - E154
  • [36] Significance of late gadolinium enhancement in cardiovascular magnetic resonance imaging (CMR)
    Voehringer, Matthias
    Mahrholdt, Heiko
    Yilmaz, Ali
    Sechtem, Udo
    HERZ, 2007, 32 (02) : 129 - 137
  • [37] Prognostic Utility of Contrast-Enhanced Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy: An International Multicenter Study
    Chan, Raymond H.
    Maron, Barry J.
    Olivotto, Iacopo
    Assenza, Gabriele
    Lesser, John R.
    Haas, Tammy
    Gruner, Christiane
    Crean, Andrew
    Rakowski, Harry
    Udelson, James E.
    Rowin, Ethan
    Tomberli, Benedetta
    Spirito, Paolo
    Formisano, Francesco
    Biagini, Elena
    Rapezzi, Claudio
    De Cecco, Carlo Nicola
    Autore, Camillo
    Cook, Earl F.
    Hong, Susie N.
    Gibson, C. Michael
    Manning, Warren J.
    Appelbaum, Evan
    Maron, Martin S.
    CIRCULATION, 2012, 126 (21)
  • [38] Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy:: Clinical implications
    Paya, Eduardo
    Marin, Francisco
    Gonzalez, Josefa
    Ramon Gimeno, Juan
    Feliu, Eloisa
    Romero, Antonio
    Ruiz-Espejo, Francisco
    Roldan, Vanessa
    Climent, Vicente
    de la Morena, Gonzalo
    Valdes, Mariano
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (05) : 414 - 419
  • [39] Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
    Tevfik F Ismail
    Andrew Jabbour
    Ankur Gulati
    Amy Mallorie
    Sadaf Raza
    Thomas E Cowling
    Bibek Das
    Jahanzaib Khwaja
    Rick Wage
    James Moon
    Amanda Varnava
    Carl Shakespeare
    Perry Elliott
    Rory OHanlon
    Dudley J Pennell
    Sanjay K Prasad
    Journal of Cardiovascular Magnetic Resonance, 15 (Suppl 1)
  • [40] Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia
    Paweł Petkow Dimitrow
    Piotr Klimeczek
    Rozemarijn Vliegenthart
    Mieczysław Pasowicz
    Matthijs Oudkerk
    Piotr Podolec
    Wiesława Tracz
    Jacek S. Dubiel
    The International Journal of Cardiovascular Imaging, 2008, 24 : 77 - 83